section name header

Use and Dosing ⬇

Adult Dosing

Vulvovaginal candidiasis

Adults, nonpregnant

Pediatric Dosing

Indications ⬆ ⬇

Contraindications ⬆ ⬇

Dosing Adjustment ⬆ ⬇

Renal Dose Adjustment

Hepatic Dose Adjustment

Warnings/Precautions ⬆ ⬇

See Supplemental Patient Information

Supplemental Patient Information

Pregnancy/Breast Feeding ⬆ ⬇

Pregnancy Category:C

Breastfeeding: Safety unknown. No published experience with butoconazole, other agents might be preferred, especially while nursing a newborn or preterm infant. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 10 May 2010). Manufacturer advises caution

Adverse Reactions ⬆ ⬇

Clinical Pharmacology ⬆ ⬇

Brands and Availability ⬆ ⬇

flag_usa32.png

US Trade Name(s)

US Availability

Gynazole-1

Femstat 3

flag_canada32.png

Canadian Trade Name(s)

Canadian Availability

Gynazole 1

flag_uk32.png

UK Trade Name(s)

UK Availability

flag_australia32.png

Australian Trade Name(s)

Australian Availability

Gynazole-1

Classification ⬆

Antimicrobials

Vaginal Agents; Anti-infectives

Infectious Disease

Vaginal Agents; Anti-infectives

Obstetrics/Gynecology

Vaginal Agents; Anti-infectives